Measurement of Tissue Oxygen Saturation in Chronic Critical Limb Ischemia

Sponsor
ViOptix Canada (Industry)
Overall Status
Terminated
CT.gov ID
NCT00224328
Collaborator
(none)
100
1
17
5.9

Study Details

Study Description

Brief Summary

Near-infrared spectroscopy can be used to determine the relative oxygen saturation in tissues up to 2cm below the skin. It has been investigated, with success, in cerebral, gastrointestinal, and muscle tissue, and shows promise in numerous indications involving tissue ischemia. In the current study, we propose to examine one hundred patients requiring either bypass or angioplasty due to chronic critical limb ischemia resulting from peripheral arterial disease. We intend to challenge patients before and after the intervention, using either an inflated blood pressure cuff or toe raises, to determine if oxygen saturation recovery time in the affected limb is correlated with symptom resolution (i.e. treatment success). Near-infrared spectroscopy will be performed using the ODISsey tissue oximeter developed by ViOptix, Inc. The proposed study will take approximately one year to complete enrolment, and has a follow-up period of 6 months post-intervention.

Study Hypothesis: Knowledge of tissue oxygen saturation enhances clinical decision making in patients with chronic critical limb ischemia.

Condition or Disease Intervention/Treatment Phase
  • Device: ODISsey Tissue Oximeter

Study Design

Study Type:
Observational
Anticipated Enrollment :
100 participants
Observational Model:
Defined Population
Time Perspective:
Prospective
Official Title:
Measurement of Tissue Oxygen Saturation in Chronic Critical Limb Ischemia: A Phase Iia, Non-Randomized Study Using the ODISsey Tissue Oximeter to Evaluate the Correlation Between Tissue Oxygen Saturation and Symptom Resolution in Patients With Chronic Critical Limb Ischemia Undergoing Treatment Interventions
Study Start Date :
Aug 1, 2005
Actual Study Completion Date :
Jan 1, 2007

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • = 18 years old

    • PAD

    • Chronic Critical Limb Ischemia

    • requiring surgical intervention

    • able to give informed consent

    Exclusion Criteria:
    • emergent/urgent requirement for surgical intervention

    • requiring surgical intervention due to acute traumatic injury

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Toronto General Hospital Toronto Ontario Canada M5G 2C4

    Sponsors and Collaborators

    • ViOptix Canada

    Investigators

    • Principal Investigator: Thomas Lindsay, FRCSC, FACS, Toronto General Hospital, University Health Network

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00224328
    Other Study ID Numbers:
    • VIO-UHN-001
    First Posted:
    Sep 22, 2005
    Last Update Posted:
    Sep 12, 2007
    Last Verified:
    Sep 1, 2007

    Study Results

    No Results Posted as of Sep 12, 2007